Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | AMGN | GILD | BIIB | CELG |
| Company | Revance Therapeutics | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.12 | 301.75 | 65.43 | 221.52 | 108.01 |
| High | 4.27 | 302.91 | 66.14 | 221.98 | 108.59 |
| Low | 4.11 | 299.92 | 65.16 | 216.08 | 107.27 |
| Last | 4.21 | 300.87 | 65.84 | 217.06 | 108.24 |
| Change | +0.11 | +1.39 | +0.30 | -4.36 | +0.11 |
| % Change | +2.68% | +0.46% | +0.46% | -1.97% | +0.10% |
| Volume | 320,540 | 830,674 | 1,482,591 | 365,641 | 191,230,496 |
| 20-Day Average Volume | 1,803,205 | 2,741,396 | 7,309,035 | 1,336,669 | 16,188,930 |
| Previous Close | 4.10 | 299.48 | 65.54 | 221.42 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 3.84 | 275.36 | 66.48 | 204.43 | 108.17 |
| 20-Day Raw Stochastic | 72.55% | 66.68% | 28.36% | 82.57% | 63.25% |
| 20-Day Relative Strength | 47.38% | 63.74% | 36.62% | 54.62% | 64.69% |
| Weighted Alpha | -82.29 | +29.13 | -19.45 | -28.23 | +46.30 |
| Today's Opinion | 88% Sell | 40% Buy | 100% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 88% Sell | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 100% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.34% since 04/30/24 | +10.23% since 04/30/24 | +1.03% since 04/30/24 | +0.85% since 04/30/24 | -1.97% since 11/13/19 |
| Low | 3.65 on 05/01/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 213.11 on 05/03/24 | 107.27 on 11/20/19 |
| High | 4.26 on 05/07/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 222.40 on 05/06/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -4.76% since 04/05/24 | +11.86% since 04/05/24 | -5.33% since 04/05/24 | +6.27% since 04/05/24 | +5.14% since 10/18/19 |
| Low | 3.21 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 4.94 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 222.40 on 05/06/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -21.93% since 02/07/24 | +2.06% since 02/07/24 | -11.49% since 02/07/24 | -9.93% since 02/07/24 | +13.63% since 08/20/19 |
| Low | 3.21 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 7.56 on 03/01/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 244.95 on 02/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -51.11% since 11/07/23 | +11.38% since 11/07/23 | -18.29% since 11/07/23 | -11.79% since 11/07/23 | +14.14% since 05/20/19 |
| Low | 3.21 on 04/26/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 9.74 on 01/02/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 427,286 | 160,633,888 | 81,602,352 | 32,238,088 | 77,035,920 |
| Shares Outstanding, K | 104,216 | 536,376 | 1,245,077 | 145,597 | 711,714 |
| Annual Sales | 234,040,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -323,990,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 69,800,000 | 7,447,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
| Last Quarter Net Income | -55,700,000 | -113,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
| 60-Month Beta | 1.16 | 0.60 | 0.22 | -0.01 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 02/28/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 16.07 | 14.50 | 10.99 |